Clin2
NCT06565507Possibly a fitNot yet recruiting

Oxfendazole for a single brain cysticercosis lesion

Brain Cysticercosis

Part of Brain & nervous system, Infections clinical trials.

This study tests a medicine called oxfendazole (a type of anti-parasite drug, similar to albendazole) to treat a common form of brain infection caused by a pork tapeworm. If you have just one small lesion from this infection, this treatment may help reduce symptoms and prevent future seizures.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
544 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You must be between 18 and 75 years old
  • Your brain scan (CT or MRI) must show one small spot (a single granuloma) caused by the pork tapeworm
  • You must be willing to use effective birth control (both men and women who can have children)
  • Your blood test results for red blood cells, platelets, white blood cells, sugar, kidney, and liver function must be normal
  • You must be able to give written informed consent

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06376396Not yet recruiting· Phase 4
Two medicines vs one for brain tapeworm infection

This study tests whether giving two medicines (praziquantel and albendazole) together works better than just one medicine (albendazole) to kill the parasite that causes neurocysticercosis. If you have this brain infection and have had seizures, you might be able to participate.

NCT06367361Not yet recruiting· Phase 2
Treating chronic fascioliasis with oxfendazole or triclabendazole

This study compares two different medicines (oxfendazole and triclabendazole) to treat chronic fascioliasis, a parasitic liver infection. It aims to find the most effective and safe treatment option.

NCT04713787Recruiting· Phase 2
Test higher doses of oxfendazole against single-dose albendazole

This trial studies which dose of oxfendazole works best and is safest for treating a specific intestinal worm infection in adults. It compares different oxfendazole doses to one standard dose of albendazole, and uses stool and blood testing over about 4–6 weeks.

Santa Clara, Maynas
NCT03435718Not yet recruiting· Phase 2
Oxfendazole for whipworm infection in adults

This study tests a medication called oxfendazole to see if it can get rid of whipworm infection in adults. Participants take the medication and provide stool samples over a few weeks to see if the worms are gone.

NCT07074444Recruiting
Treating clonorchiasis with three different drugs

This study compares three medicines (albendazole, tribendimidine, and praziquantel) to see which works best for treating clonorchiasis (a liver fluke infection). If you have been diagnosed with this infection, this trial may help find the most effective treatment for you.

Nanning, Guangxi
NCT06613997Not yet recruiting· Phase 3
Albendazole for Loa loa worm infection

This trial is testing the drug albendazole in people who have Loa loa, a worm infection that can cause itchy swellings. The study will see if a 21-day course of albendazole helps clear the infection better than a placebo.

Hear when a new Brain Cysticercosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.